Page last updated: 2024-10-22

albendazole and Stevens-Johnson Syndrome

albendazole has been researched along with Stevens-Johnson Syndrome in 2 studies

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saka, B1
Akakpo, AS1
Teclessou, J1
Kassang, P1
Lowa, P1
Takassi, E1
Mahamadou, G1
Mouhari-Toure, A1
Kombaté, K1
Pitché, P1
Dewerdt, S1
Machet, L1
Jan-Lamy, V1
Lorette, G1
Therizol-Ferly, M1
Vaillant, L1

Other Studies

2 other studies available for albendazole and Stevens-Johnson Syndrome

ArticleYear
[Cutaneous lichen planus following Stevens-Johnson syndrome: Wolf's isotopic response].
    Annales de dermatologie et de venereologie, 2019, Volume: 146, Issue:12

    Topics: Albendazole; Antiprotozoal Agents; Betamethasone; Child; Female; Glucocorticoids; Humans; Injections

2019
Stevens-Johnson syndrome after albendazole.
    Acta dermato-venereologica, 1997, Volume: 77, Issue:5

    Topics: Albendazole; Anthelmintics; Humans; Male; Middle Aged; Stevens-Johnson Syndrome; Toxocariasis

1997